Inotiv

Inotiv, Inc. was founded with the mission to provide comprehensive drug discovery, development, and consulting services to the pharmaceutical and medical device industries. The company operates through two main segments: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). Inotiv offers a range of services including nonclinical and analytical drug discovery, safety assessment, and the manufacturing of scientific instruments and related software for life sciences research. Their market focus includes pharmaceutical companies, universities, government research centers, and medical research institutions.

Notable affiliated individuals include key scientific leaders and experienced professionals in the pharmaceutical and medical device sectors. Inotiv has attracted significant investment from stakeholders interested in advancing drug discovery and development. Key achievements include the development of innovative tools like Target Sufficiency® for quantitative analysis of drug target systems. Overall, Inotiv has made a substantial impact by supporting critical research efforts, reducing costs for clients, and enhancing the efficiency of drug development processes globally.